Lamivudine and HBV-associated nephropathy.
Izzedine
Hassane
H
Massard
Julien
J
Poynard
Thierry
T
Deray
Gilbert
G
D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000821:virology; D018347:Hepadnaviridae Infections / Q000188:drug therapy* / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine